Drug intelligence / Profile preview

iron dextran

Development stage
Approved
Lead developer
American Regent
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Iron dextran is an intravenous or intramuscular iron replacement medication used to treat iron deficiency anemia in patients for whom oral iron is ineffective or intolerable. It consists of a complex of ferric hydroxide and dextran, which is processed by the reticuloendothelial system to release elemental iron. This iron then binds to transferrin and is transported to the bone marrow for incorporation into hemoglobin. Iron dextran is notable for its ability to be administered as a total dose infusion (TDI), allowing for the correction of a patient's entire iron deficit in a single session. However, its use requires a test dose due to the risk of serious anaphylactoid reactions, which were historically more common with high molecular weight formulations.

Brand names
CosmoFerInfedDexferrumImferon
Other names
iron dextran complexlow molecular weight iron dextranLMWIDhigh molecular weight iron dextranHMWID
02

Targets

FTH1 (Ferritin heavy chain 1)

Beyond the preview

Go deeper on iron dextran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iron dextran.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call